血管质量倡议中静脉消融后缺乏临床改善的相关因素
该回顾性分析纳入2014至2023年血管质量倡议静脉曲张数据库中因CEAP C2至C4疾病接受单次静脉消融的3544例患者,其中2607例有术前术后VCSS评分,420例(16.1%)缺乏临床改善。多因素回归显示年龄、肥胖、治疗较轻疾病(CEAP C2 vs C4)及术前缺乏压力治疗与缺乏临床改善独立相关,而静脉直径与临床改善无显著关联。
要点
- 静脉消融后16.1%的患者缺乏临床改善(ΔVCSS≤0)。
- 治疗CEAP C2较C4疾病与缺乏临床改善独立相关(OR 1.82)。
- 术前缺乏压力治疗与缺乏临床改善独立相关(OR 6.05)。
核心结论
- 静脉消融后缺乏临床改善与治疗较低CEAP分级(C2 vs C4)及术前缺乏压力治疗相关。
- 静脉大小与临床改善之间未观察到显著关联。
研究设计与样本
- 回顾性分析2014至2023年血管质量倡议静脉曲张数据库中因CEAP C2至C4疾病接受单次静脉消融的患者。
- 排除需要多静脉干预、既往接受过干预或CEAP C5至C6疾病的患者。
- 共3544例患者接受初始单次静脉消融治疗,其中2607例有术前术后VCSS评分。
- 以VCSS差值(术前减术后)≤0定义为缺乏临床改善,≥1分下降定义为临床改善。
- 另基于VVSymQ量表(评估沉重、酸痛、肿胀、搏动性疼痛和瘙痒五个症状)进行第二项分析。
主要发现
- 2607例有VCSS评分的患者中,420例(16.1%)缺乏临床改善。
- 缺乏临床改善的患者年龄显著更大、非裔美国人比例更高、CEAP C2疾病比例更高。
- 临床改善的患者术前使用压力袜的比例更高。
- 两组静脉直径无差异;并发症发生率总体较低,两组间有微小差异。
- 缺乏临床改善的患者干预后症状比例显著更高,且更可能出现技术失败(静脉再通)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Insurance companies have adopted variable and inconsistent approval criteria for chronic venous disease (CVD) treatment. Although vein ablation (VA) is accepted as the standard of care for venous ulcers, the treatment criteria for patients with milder forms of CVD remain controversial. This study aims to identify factors associated with a lack of clinical improvement (LCI) in patients with less severe CVD without ulceration undergoing VA to improve patient selection for treatment. METHODS: We performed a retrospective analysis of patients undergoing VA for CEAP C2 to C4 disease in the Vascular Quality Initiative varicose veins database from 2014 to 2023. Patients who required intervention in multiple veins, had undergone prior interventions, or presented with CEAP C5 to C6 disease were excluded. The difference (Δ) in venous clinical severity score (VCSS; VCSS before minus after the procedure) was used to categorize the patients. Patients with a ΔVCSS of ≤0 were defined as having LCI after VA, and patients with ≥1 point decrease in the VCSS after VA (ΔVCSS ≥1) as having some benefit from the procedure and, therefore, "clinical improvement." The characteristics of both groups were compared, and multivariable regression analysis was performed to identify factors independently associated with LCI. A second analysis was performed based on the VVSymQ instrument, which measures patient-reported outcomes using five specific symptoms (ie, heaviness, achiness, swelling, throbbing pain, and itching). Patients with LCI showed no improvement in any of the five symptoms, and those with clinical improvement had a decrease in severity of at least one symptom. RESULTS: A total of 3544 patients underwent initial treatment of CVD with a single VA. Of the 3544 patients, 2607 had VCSSs available before and after VA, and 420 (16.1%) had LCI based on the ΔVCSS. Patients with LCI were more likely to be significantly older and African American and have CEAP C2 disease compared with patients with clinical improvement. Patients with clinical improvement were more likely to have reported using compression stockings before treatment. The vein diameters were not different between the two groups. The incidence of complications was overall low, with minor differences between the two groups. However, the patients with LCI were significantly more likely to have symptoms after intervention than those with improvement. Patients with LCI were more likely to have technical failure, defined as vein recanalization. On multivariable regression, age (odds ratio [OR], 1.01; 95% confidence interval [CI], 1.00-1.02) and obesity (OR, 1.47; 95% CI, 1.09-2.00) were independently associated with LCI, as was treatment of less severe disease (CEAP C2; OR, 1.82; 95% CI, 1.30-2.56) compared with more advanced disease (C4). The lack of compression therapy before intervention was also associated with LCI (OR, 6.05; 95% CI, 4.30-8.56). The analysis based on the VVSymQ showed similar results. CONCLUSIONS: LCI after VA is associated with treating patients with a lower CEAP class (C2 vs C4) and a lack of compression therapy before intervention. Importantly, no significant association between vein size and clinical improvement was observed.
引用
- Pinto Rodríguez P, Fassler M, Obi A, et al. Factors associated with lack of clinical improvement after vein ablation in the vascular quality initiative. J Vasc Surg Venous Lymphat Disord. 2024. PMID: 38552954. doi:10.1016/j.jvsv.2024.101884
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。